Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction?

被引:8
作者
Singh, Awadhesh Kumar [1 ]
Singh, Ritu [1 ]
Misra, Anoop [2 ]
机构
[1] GD Hosp & Diabet Inst, Dept Diabet & Endocrinol, Kolkata, India
[2] Fortis CDOC Hosp Diabet & Allied Sci, Dept Diabet, New Delhi, India
关键词
cardiovascular death; heart failure hospitalization; preserved ejection fraction; reduced ejection fraction; SGLT-2; inhibitors;
D O I
10.1111/1753-0407.13182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:596 / 600
页数:5
相关论文
共 14 条
  • [1] Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Shahzeb Khan, Muhammad
    Pedro Ferreira, Joao
    Bocchi, Edimar
    Bohm, Michael
    Pieter Brunner-La Rocca, Hans
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio, V
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Seronde, Marie-France
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2383 - 2392
  • [2] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 129 - 139
  • [3] Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
    Cosentino, Francesco
    Cannon, Christopher P.
    Cherney, David Z. I.
    Masiukiewicz, Urszula
    Pratley, Richard
    Dagogo-Jack, Sam
    Frederich, Robert
    Charbonnel, Bernard
    Mancuso, James
    Shih, Weichung J.
    Terra, Steven G.
    Cater, Nilo B.
    Gantz, Ira
    McGuire, Darren K.
    [J]. CIRCULATION, 2020, 142 (23) : 2205 - 2215
  • [4] Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrumof heart failure risk in the EMPA-REG OUTCOME® trial
    Fitchett, David
    Butler, Javed
    van de Borne, Philippe
    Zinman, Bernard
    Lachin, John M.
    Wanner, Christoph
    Woerle, Hans J.
    Hantel, Stefan
    George, Jyothis T.
    Johansen, Odd Erik
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (05) : 363 - 370
  • [5] Higgins JP., 2003, BMJ, V327, P557, DOI DOI 10.1136/BMJ.327.7414.557
  • [6] The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    Higgins, Julian P. T.
    Altman, Douglas G.
    Gotzsche, Peter C.
    Jueni, Peter
    Moher, David
    Oxman, Andrew D.
    Savovic, Jelena
    Schulz, Kenneth F.
    Weeks, Laura
    Sterne, Jonathan A. C.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [7] Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
    Kato, Eri T.
    Silverman, Michael G.
    Mosenzon, Ofri
    Zelniker, Thomas A.
    Cahn, Avivit
    Furtado, Remo H. M.
    Kuder, Julia
    Murphy, Sabina A.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Bonaca, Marc P.
    Ruff, Christian T.
    Desai, Akshay S.
    Goto, Shinya
    Johansson, Peter A.
    Gause-Nilsson, Ingrid
    Johanson, Per
    Langkilde, Anna Maria
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    [J]. CIRCULATION, 2019, 139 (22) : 2528 - 2536
  • [8] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
  • [9] Effects of sodium glucose cotransporter type 2 inhibitors on heart failure
    Nassif, Michael E.
    Kosiborod, Mikhail
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 : 19 - 23
  • [10] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Carson, Peter
    Januzzi, James
    Verma, Subodh
    Tsutsui, Hiroyuki
    Brueckmann, Martina
    Jamal, Waheed
    Kimura, Karen
    Schnee, Janet
    Zeller, Cordula
    Cotton, Daniel
    Bocchi, Edimar
    Boehm, Michael
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Janssens, Stefan
    Zhang, Jian
    Juanatey, Jose R. Gonzalez
    Kaul, Sanjay
    Brunner-La Rocca, Hans-Peter
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio
    Pina, Ileana
    Ponikowski, Piotr
    Sattar, Naveed
    Senni, Michele
    Seronde, Marie-France
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Wanner, Christoph
    Zannad, Faiez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) : 1413 - 1424